Pre-exposure prophylaxis works--it's time to deliver

Lancet. 2015 Apr 18;385(9977):1482-4. doi: 10.1016/S0140-6736(15)60724-3.

Authors

Chris Beyrer¹, Linda-Gail Bekker², Anton Pozniak³, Françoise Barré-Sinoussi⁴

Affiliations

¹ Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: [email protected].
² Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
³ Chelsea and Westminster NHS Foundation Trust, London, UK.
⁴ Institute Pasteur, Paris, France.

PMID: 25933264
DOI: 10.1016/S0140-6736(15)60724-3

No abstract available

MeSH terms

Adenine / administration & dosage
Adenine / analogs & derivatives*
Anti-HIV Agents / administration & dosage*
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives*
Emtricitabine
HIV Infections / prevention & control*
Health Services Accessibility*
Humans
Organophosphonates / administration & dosage*
Pre-Exposure Prophylaxis*
Tenofovir

Substances

Anti-HIV Agents
Organophosphonates
Deoxycytidine
Tenofovir
Emtricitabine
Adenine